panaxydol has been researched along with Disease Models, Animal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, HS; Kim, JY; Kim, Y; Lim, JM; Park, S; Sohn, J | 1 |
1 other study(ies) available for panaxydol and Disease Models, Animal
| Article | Year |
|---|---|
Panaxydol, a component of Panax ginseng, induces apoptosis in cancer cells through EGFR activation and ER stress and inhibits tumor growth in mouse models.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line, Tumor; Cell Proliferation; Cisplatin; Disease Models, Animal; Diynes; Drug Synergism; eIF-2 Kinase; Endoplasmic Reticulum Stress; ErbB Receptors; Fatty Alcohols; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinases; Membrane Proteins; Mice; NADPH Oxidases; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Panax; Phospholipase C gamma; Plant Extracts; Proto-Oncogene Proteins; Reactive Oxygen Species; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |